Gland Pharma Limited
NSE:GLAND.NS
1703.4 (INR) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | 2019 Q4 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||||
Current Assets: | ||||||||||||||||||
Cash & Cash Equivalents
| 28,201.08 | -18,394.32 | 18,394.32 | -21,447.34 | 4,808.2 | -37,706.75 | 19,088.95 | -32,950.34 | 5,341.89 | -32,483.15 | 3,158.24 | -29,284.15 | 2,716.37 | -30,057.5 | 4,918.2 | 3,817.82 | 1,694.97 | -7,207.47 |
Short Term Investments
| 0 | 36,788.64 | 17,342.78 | 42,894.68 | 17,281.45 | 75,413.5 | 19,273.01 | 65,900.68 | 28,590.59 | 64,966.3 | 29,268.93 | 58,568.3 | 27,377.19 | 60,115 | 19,546.85 | 11,470.37 | 11,427.28 | 14,414.94 |
Cash and Short Term Investments
| 28,201.08 | 18,394.32 | 18,394.32 | 21,447.34 | 22,089.65 | 37,706.75 | 38,361.96 | 32,950.34 | 33,932.48 | 32,483.15 | 32,427.17 | 29,284.15 | 30,093.56 | 30,057.5 | 24,465.05 | 15,288.19 | 13,122.25 | 7,207.47 |
Net Receivables
| 14,899.73 | 0 | 16,482.07 | 0 | 13,731.37 | 0 | 9,586.53 | 0 | 12,011.86 | 0 | 12,097.02 | 0 | 10,543.5 | 0 | 6,709.71 | 6,740.22 | 6,017.85 | 0 |
Inventory
| 15,770.31 | 0 | 16,552.37 | 0 | 20,843.48 | 0 | 19,453 | 0 | 15,597.35 | 0 | 11,856.67 | 0 | 14,605.22 | 0 | 12,751.68 | 10,089.36 | 7,562.79 | 0 |
Other Current Assets
| 5,170.33 | 0 | 3,818.61 | 0 | 3,690.97 | 0 | 2,011.38 | 0 | 2,531.04 | 0 | 1,674.76 | 0 | 2,365.17 | 0 | 1,613.58 | 1,386.34 | 1,609.27 | 0 |
Total Current Assets
| 64,041.45 | 18,394.32 | 56,451.52 | 21,447.34 | 59,713.16 | 37,706.75 | 69,008.08 | 32,950.34 | 63,090.59 | 32,483.15 | 58,520.79 | 29,284.15 | 56,798.04 | 30,057.5 | 51,236.42 | 33,699.17 | 28,462.9 | 7,207.47 |
Non-Current Assets: | ||||||||||||||||||
Property, Plant & Equipment, Net
| 39,327.88 | 0 | 38,301.52 | 0 | 34,132.27 | 0 | 17,361.03 | 0 | 16,787.96 | 0 | 17,268.97 | 0 | 15,128.13 | 0 | 13,244.42 | 12,259.78 | 11,969.02 | 0 |
Goodwill
| 2,527.58 | 0 | 2,422.59 | 0 | 4,555.95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 1,124.59 | 0 | 1,122.19 | 0 | 1,540.2 | 0 | 116.61 | 0 | 122.37 | 0 | 125.35 | 0 | 128.33 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 3,652.17 | 0 | 3,544.78 | 0 | 6,096.15 | 0 | 116.61 | 0 | 122.37 | 0 | 125.35 | 0 | 128.33 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 6,559.13 | 0 | -16,101.45 | 0 | -733.66 | 0 | 5,250 | 0 | 2,000 | 0 | -26,839.59 | 0 | -19,477.33 | 506.8 | 0 | 0 |
Tax Assets
| 527.09 | 0 | 504.37 | 0 | 443.76 | 0 | 958.88 | 0 | 49.89 | 0 | -415.05 | 0 | 27,397.9 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 1,120.35 | -18,394.32 | 1,251.14 | -21,447.34 | 18,644.49 | -37,706.75 | 1,064.41 | -32,950.34 | 913.81 | -32,483.15 | 836.15 | -29,284.15 | 1,363.17 | -30,057.5 | 19,957.31 | 446.9 | 428.47 | -7,207.47 |
Total Non-Current Assets
| 44,627.49 | -18,394.32 | 50,160.94 | -21,447.34 | 43,215.22 | -37,706.75 | 18,767.27 | -32,950.34 | 23,124.03 | -32,483.15 | 19,815.42 | -29,284.15 | 17,177.94 | -30,057.5 | 13,724.4 | 13,213.48 | 12,397.49 | -7,207.47 |
Total Assets
| 108,668.94 | 0 | 106,612.46 | 0 | 102,928.38 | 0 | 87,775.35 | 0 | 86,214.62 | 0 | 78,336.21 | 0 | 73,975.98 | 0 | 64,960.82 | 46,912.65 | 40,860.39 | 0 |
Liabilities & Equity: | ||||||||||||||||||
Current Liabilities: | ||||||||||||||||||
Account Payables
| 9,976.66 | 0 | 8,626.92 | 0 | 9,782.48 | 0 | 5,873.5 | 0 | 7,018.66 | 0 | 4,628.5 | 0 | 4,833.59 | 0 | 3,963.49 | 4,774.98 | 2,490.94 | 0 |
Short Term Debt
| 2,012.1 | 0 | 2,309.47 | 0 | 2,095.9 | 0 | 7.09 | 0 | 7.09 | 0 | 2.61 | 0 | 2.61 | 0 | 2.97 | 9.93 | 10.17 | 0 |
Tax Payables
| 0 | 0 | 516.37 | 0 | 614.94 | 0 | 9.85 | 0 | 398.38 | 0 | 179.79 | 0 | 865.14 | 0 | 286.9 | 758.46 | 107.23 | 0 |
Deferred Revenue
| 1,028.33 | 0 | 516.37 | 0 | 1,117.67 | 0 | 486.08 | 0 | 753.02 | 0 | 636.57 | 0 | 1,558.56 | 0 | 286.9 | 1,656.02 | 917.95 | 0 |
Other Current Liabilities
| 2,370.5 | 0 | 1,677.12 | 0 | 1,751.03 | 0 | 640.47 | 0 | 527.08 | 0 | 670.19 | 0 | -79.58 | 0 | 529.45 | -721.23 | 63.94 | 0 |
Total Current Liabilities
| 15,387.59 | 0 | 13,983.63 | 0 | 15,362.02 | 0 | 7,291.33 | 0 | 8,704.23 | 0 | 5,820.25 | 0 | 7,180.32 | 0 | 5,125.28 | 6,478.16 | 3,590.23 | 0 |
Non-Current Liabilities: | ||||||||||||||||||
Long Term Debt
| 1,254.18 | 0 | 1,412.19 | 0 | 1,474.4 | 0 | 37.44 | 0 | 38.35 | 0 | 44.82 | 0 | 45.32 | 0 | 46.98 | 49.94 | 49.94 | 0 |
Deferred Revenue Non-Current
| 318.01 | 0 | 346.79 | 0 | 1,248.95 | 0 | 49.94 | 0 | 49.94 | 0 | 55.54 | 0 | 55.55 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 2,191.71 | 0 | 2,201.23 | 0 | 1,338.46 | 0 | 842.03 | 0 | 943.37 | 0 | 877.6 | 0 | 776.99 | 0 | 738.81 | 732.55 | 740.54 | 0 |
Other Non-Current Liabilities
| 1,637.45 | -87,238.43 | 1,776.98 | 0 | 437.46 | 0 | 859.36 | 0 | 17.33 | 0 | 894.93 | 0 | 17.34 | 0 | 17.33 | 749.88 | 757.87 | 0 |
Total Non-Current Liabilities
| 5,401.35 | -87,238.43 | 5,390.4 | 0 | 4,499.27 | 0 | 896.8 | 0 | 999.05 | 0 | 939.75 | 0 | 839.65 | 0 | 803.12 | 799.82 | 807.81 | 0 |
Total Liabilities
| 20,788.94 | -87,238.43 | 19,374.03 | 0 | 19,861.29 | 0 | 8,188.13 | 0 | 9,703.28 | 0 | 6,760 | 0 | 8,019.97 | 0 | 5,928.4 | 7,277.98 | 4,398.04 | 0 |
Equity: | ||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 15.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 164.75 | 0 | 164.71 | 0 | 164.7 | 0 | 164.7 | 0 | 164.69 | 0 | 164.3 | 0 | 164.23 | 0 | 163.59 | 154.95 | 154.95 | 0 |
Retained Earnings
| 0 | 0 | 67,878.48 | 0 | 0 | 0 | 60,153.88 | 0 | 0 | 0 | 52,343.45 | 0 | 0 | 0 | 40,226.81 | 33,393.08 | 30,257.18 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | 87,238.43 | 87,073.72 | 83,067.09 | 82,902.39 | 79,587.22 | -15.59 | 76,511.34 | 76,346.65 | 71,576.21 | 114.54 | 65,956.01 | 65,791.78 | 59,032.42 | 18,564.68 | 165.48 | 129.06 | 28,619.99 |
Other Total Stockholders Equity
| 87,715.25 | 0 | 19,292.29 | 0 | 0 | 0 | 19,284.23 | 0 | 0 | 0 | 18,953.92 | 0 | 0 | 0 | 18,401.09 | 5,889.94 | 5,889.94 | 0 |
Total Shareholders Equity
| 87,880 | 87,238.43 | 87,238.43 | 83,067.09 | 83,067.09 | 79,587.22 | 79,587.22 | 76,511.34 | 76,511.34 | 71,576.21 | 71,576.21 | 65,956.01 | 65,956.01 | 59,032.42 | 59,032.42 | 39,634.67 | 36,462.35 | 28,619.99 |
Total Equity
| 87,880 | 87,238.43 | 87,238.43 | 83,067.09 | 83,067.09 | 79,587.22 | 79,587.22 | 76,511.34 | 76,511.34 | 71,576.21 | 71,576.21 | 65,956.01 | 65,956.01 | 59,032.42 | 59,032.42 | 39,634.67 | 36,462.35 | 28,619.99 |
Total Liabilities & Shareholders Equity
| 108,668.94 | 87,238.43 | 106,612.46 | 83,067.09 | 102,928.38 | 79,587.22 | 87,775.35 | 76,511.34 | 86,214.62 | 71,576.21 | 78,336.21 | 65,956.01 | 73,975.98 | 59,032.42 | 64,960.82 | 46,912.65 | 40,860.39 | 28,619.99 |